Latest News and Press Releases

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Anti-Cancer MAbS Market Report 2025" has been added to ResearchAndMarkets.com's offering. The anti-cancer monoclonal antibodies (mAbs) market is...

Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "Invasive Ductal Carcinoma Treatment Market by Therapy, by Type, by Distribution Channel, and By Region" report has been added to ...

Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Oncology Based in-Vivo CRO - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...

Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Oncology-based In-Vivo CRO Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Industry Anticipates Major...

SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that optical genome mapping (OGM) was included for the first time in the American College of...

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Immuno-oncology Clinical Trials Market by Design (Expanded Access Trials, Interventional Trials, Observational Trials), Phase (Phase I, Phase...

Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Anti-Cancer MAbS Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The Anti-Cancer Monoclonal Antibodies (MAbs)...

Dublin, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The "Oncology Based In-Vivo CRO Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global market for...

NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) --  Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...

Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- In a recent groundbreaking study published on October 3rd in the open access journal PLOS Medicine, Thomas Callender of University College London and his...